Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 13 2 2020
pubmed: 13 2 2020
medline: 19 3 2020
Statut: ppublish

Résumé

A novel coronavirus (2019-nCoV) is causing an outbreak of viral pneumonia that started in Wuhan, China. Using the travel history and symptom onset of 88 confirmed cases that were detected outside Wuhan in the early outbreak phase, we estimate the mean incubation period to be 6.4 days (95% credible interval: 5.6-7.7), ranging from 2.1 to 11.1 days (2.5th to 97.5th percentile). These values should help inform 2019-nCoV case definitions and appropriate quarantine durations.

Identifiants

pubmed: 32046819
doi: 10.2807/1560-7917.ES.2020.25.5.2000062
pmc: PMC7014672
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Lancet Infect Dis. 2014 Jan;14(1):50-56
pubmed: 24239323
Int J Infect Dis. 2020 Jan 30;92:214-217
pubmed: 32007643
J Clin Med. 2020 Jan 24;9(2):
pubmed: 31991628
N Engl J Med. 2020 Jan 29;:
pubmed: 31995857
N Engl J Med. 2013 Aug 1;369(5):407-16
pubmed: 23782161
Lancet. 2020 Jan 31;:
pubmed: 32014114
Lancet. 2003 May 24;361(9371):1761-6
pubmed: 12781533
BMC Infect Dis. 2010 Mar 06;10:50
pubmed: 20205928
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Sci Rep. 2016 Oct 24;6:35839
pubmed: 27775012
Epidemiology. 2007 Mar;18(2):253-9
pubmed: 17235210
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959

Auteurs

Jantien A Backer (JA)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Don Klinkenberg (D)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Jacco Wallinga (J)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH